Parallel

company

About

Parallel cultivates, produces, and processes cannabis for medical purposes.

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$10M
Industries
Cannabis,Health Care,Personal Health,Therapeutics,Wellness
Founded date
Jan 2, 2014
Number Of Employee
501 - 1000
Operating Status
Active
Legal Name
Surterra Holdings, Inc.
Also Known As
Surterra Holdings,Surterra,Parallel

Parallel cultivates, produces, and processes cannabis for medical purposes. It also operates a marijuana dispensary. The company's mission is to provide the safest, highest quality cannabis-based products that empower health and enable them to live well.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
8
$365.74M
Parallel has raised a total of $365.74M in funding over 2 rounds. Their latest funding was raised on Dec 8, 2022 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 8, 2022 Debt Financing $10M 1 SunStream Detail
Jan 1, 2021 Series Unknown 1 Detail
Jun 27, 2019 Series D $100M 1 Edward Brown Detail
Apr 13, 2019 Debt Financing $165.42M Detail
Aug 6, 2018 Series C $65M Detail

Investments

Number of Investments
Number of Lead Investments
3
1
Parallel has made 3 investments. Their most recent investment was on Jan 25, 2022, when Atomic Form raised $4.50M.
Date Company Name
Round Money Raised Industry Lead Investor
Jan 25, 2022 Atomic Form
Seed $4.50M Cryptocurrency
Grant $3M Education Yes
Series Unknown $1.08M Cannabis

Investors

Number of Lead Investors
Number of Investors
2
3
Parallel is funded by 3 investors. SunStream and Edward Brown are the most recent investors.
Investor Name Lead Investor Funding Round
SunStream Yes Debt Financing
Edward Brown Yes Series D
Poseidon Asset Management Series Unknown

Employee Profiles

Number of Employee Profiles
1
Parallel has 1 current employee profiles, including Employee Jeffrey Dalton
Employee

Acquisition

Parallel has acquired 3 organizations. Their most recent acquisition was New England Treatment Access on Jan 14, 2019. They acquired New England Treatment Access for 0.

Date Company Name
Industry Acquisition Type Price
Alternative Medicine acquisition Detail
Biopharma acquisition Detail
Fitness acquisition Detail